RE:RE:Fantasy and truth"Why should the bar be some random index?"
Not random. Performance is generally benchmarked against industry peers. Ideally CZO's performance would be measured against Canadian microcap biotech. Different sectors behave differently at different times so you compare against sector peers. You aim to beat your peers generally.
The truth is that we've been in the worst biotech bear market in history and microcap biotech has been hit the worst. CZO's ability to generate funds internally with its base business has kept it viable and moving forward. CZO has enough money to get to key milestones and the ability to pick over other struggling biotech microcaps and opportunities as it seeks a NASDAQ listing.